Qube Research & Technologies (QRT)
SRTA

Qube Research & Technologies (QRT)’s Strata Critical Medical Inc SRTA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
+524,627
New +$2.76M ﹤0.01% 1972
2026
Q1 		– Sell
-80,035
Closed -$385K – 3552
2025
Q4 		$385K Sell
80,035
-369,573
-82% -$1.79M ﹤0.01% 2875
2025
Q3 		$2.28M Buy
449,608
+150,984
+51% +$667K ﹤0.01% 2180
2025
Q2 		$1.2M Buy
298,624
+150,711
+102% +$491K ﹤0.01% 2396
2025
Q1 		$404K Buy
+147,913
New +$531K ﹤0.01% 2625
2024
Q1 		– Sell
-9,658
Closed -$34.1K – 4473
2023
Q4 		$34.1K Buy
+9,658
New +$27.7K ﹤0.01% 3393
2022
Q1 		– Sell
-21,380
Closed -$189K – 2461
2021
Q4 		$189K Buy
+21,380
New +$203K ﹤0.01% 1993
2021
Q2 		– Sell
-36,075
Closed -$371K – 2278
2021
Q1 		$371K Buy
+36,075
New +$502K 0.01% 1343

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SRTA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 524,627 shares worth $2.76M. The stake represents ﹤0.01% of the portfolio and ranks #1972 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in SRTA as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in SRTA in Q1 2021 and has held it in 8 quarters since. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 524,627 shares of Strata Critical Medical Inc worth $2.76M as of Q2 2026.
  • Strata Critical Medical Inc was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1972 holding.
  • Qube Research & Technologies (QRT) first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 8 quarters since.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.